British-Swedish pharmaceutical company
AstraZeneca ▸ Facts ▸ Comments ▸ News ▸ Videos
EU medicines regulator launches blood clots probe related to Johnson & Johnson vaccine
Credit: euronews (in English) Duration: 03:02Published
Credit: FRANCE 24 English Duration: 02:28Published
Mexico gov't says it will continue to use AstraZeneca
Credit: Al Jazeera STUDIO Duration: 02:08Published
Oxford Vaccine Group on AZ jab
Credit: ODN Duration: 00:47Published
Blood clot victim’s sister speaks
Credit: ODN Duration: 01:02Published
People under 30 to be offered alternative Covid vaccine to AstraZeneca jab
Credit: Cover Video STUDIO Duration: 01:03Published
AstraZeneca vaccine & blood clots: Is there a real link? | Oneindia News
Credit: Oneindia Duration: 01:23Published
Sturgeon: I would take AZ jab ‘without hesitation’
Credit: ODN Duration: 00:44Published
Vaccine programme still ‘on track’ after new AZ jab advice
Credit: ODN Duration: 01:00Published
Credit: FRANCE 24 English Duration: 01:48Published
AstraZeneca vaccine comes under further pressure in EU, UK
Credit: Al Jazeera STUDIO Duration: 02:36Published
EU agency finds AstraZeneca vaccine can cause rare blood clots
Credit: Bleacher Report AOL Duration: 02:03Published
Should I be worried about the AstraZeneca Covid-19 vaccine?
Credit: PA - Press Association STUDIO Duration: 01:40Published
PM: We’ll make sure people get the right jabs
Credit: ODN Duration: 00:39Published
Jeremy Hunt: JCVI advice on AZ vaccine is ‘sensible’
Credit: ODN Duration: 00:51Published
Boris Johnson says AstraZeneca decision will not affect road map out of lockdown
Credit: PA - Press Association STUDIO Duration: 01:28Published
EMA: Benefits of AstraZeneca jab outweigh risks
Credit: PA - Press Association STUDIO Duration: 01:35Published
PM: End of lockdown road map will not be deterred by MHRA guidance on AstraZeneca jab
Credit: PA - Press Association STUDIO Duration: 01:32Published
JCVI: Under-30s to be offered alternative to AZ vaccine
Credit: ODN Duration: 01:34Published
AstraZeneca jab benefits ‘outweigh risks’ but under-30s offered alternative
Credit: PA - Press Association STUDIO Duration: 01:13Published
Minister: No causal link between AZ vaccine and blood clots
Credit: ODN Duration: 00:30Published
JCVI member: Both vaccines in use highly effective against Covid
Credit: PA - Press Association STUDIO Duration: 00:18Published
Credit: FRANCE 24 English Duration: 02:47Published
PM: Covid status certification 'probably going to be fact of life' for overseas travel
Credit: PA - Press Association STUDIO Duration: 01:21Published
PM urges people to continue getting AstraZeneca vaccine
Credit: ODN Duration: 00:46Published
You Might Like
India to review Covid-19 vaccines after blood clot warning: ReportA government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two Covid-19 vaccines being administered in India, a media report said..
Blood clot victim's sister 'very angry' but says everyone should have Oxford jabThe sister of a man who died from a blood clot after receiving the Oxford-AstraZeneca vaccine has said she is "very angry" but still "strongly" believes people should have the vaccine.
More than 700,000 doses of AstraZeneca jab 'flown from UK to Australia'More than 700,000 doses of the Oxford-AstraZeneca vaccine have been flown from the UK to Australia, it has been reported.
Oxford jab scientist set for £20m windfall in 'New York flotation'The scientist who led the development of the Oxford University-AstraZeneca coronavirus vaccine is on course for a payday of more than £20m through a stock market listing, according to reports.
'Full speed ahead' for vaccine rollout - but 18 to 29-year-olds to be offered alternative to Oxford jabBoris Johnson has said the roadmap out of lockdown will not be affected by the decision to offer 18 to 29-year-olds an alternative to the Oxford-AstraZeneca vaccine.
AstraZeneca sends legal notice to SII over delays in vaccine supply
What is the AstraZeneca blood clot risk and how does it compare?The use of the Oxford-AstraZeneca vaccine in those under 30 is to be limited due to concerns over blood clots - but what exactly is the risk and how does it compare?
Serum Institute asks government for $403 million to boost AstraZeneca vaccine outputThe Serum Institute of India has asked the government for a grant of 30 billion rupees ($402.97 million) to increase its capacity to make AstraZeneca's Covid-19 vaccine. It is seeking the money to ramp..
'Unusual blood clots' should be listed as 'very rare' side effect of Oxford vaccine, EU regulator saysThe European medicines regulator says that "unusual blood clots" should be listed as "very rare" side-effects of the Oxford-AstraZeneca COVID vaccine.
Britons aged 18-29 to be offered alternative to Oxford jabBritons aged 18-29 will be offered an alternative to the Oxford-AstraZeneca vaccine where available, government advisors have decided.
Does the AstraZeneca vaccine still pass the risk-benefit analysis for young people?The greater the risk of a disease, the greater the risk doctors would be prepared to take to prevent it.
Everything you need to know about the Moderna vaccineThe Moderna coronavirus vaccine is the third jab to be rolled out in the UK, alongside the Pfizer/BioNTech and Oxford University-AstraZeneca jabs.
UK trial of Oxford COVID jab on children paused as regulator probes blood clots in adultsA trial of the Oxford-AstraZeneca COVID vaccine on children in the UK has been paused while the medicines regulator investigates a possible link between the jab and rare blood clots in adults.
EU medical regulator's chief: 'Increasingly difficult' to say no link between Oxford jab and rare blood clotsThe head of the European Medicines Agency (EMA) has said it is "increasingly difficult" to say there is "no cause and effect relationship" between the Oxford-AstraZeneca jab and "rare cases of unusual..
Oxford jab benefits outweigh 'rare incidents of risk', says minister - as clot cases are reviewedThe benefits of taking the Oxford-AstraZeneca jab "far outweigh" any "rare incidents of risk", the vaccines minister has said, as the UK's drugs regulator investigates reports of blood clots.
Regulator says Oxford-AstraZeneca jab is safe despite seven UK blood clot deathsSeven people have died from blood clots after taking the Oxford-AstraZeneca coronavirus vaccine in the UK.
Thirty blood clot cases reported in UK after 18 million Oxford jabsThirty blood clotting cases were reported in the UK after the first 18 million doses of the Oxford-AstraZeneca vaccine, the medicines regulator has said.
EU seeks 10 million AstraZeneca vaccines from India to meet shortfall: Indian sourcehe European Union has asked India to allow it to buy 10 million doses of AstraZeneca's Covid-19 vaccine from Serum Institute of India, a government official told Reuters, the latest sign of growing..
UK '100% confident' in AstraZeneca jab after Germany suspends use in under-60sThe UK is "100% confident in the efficacy" of the Oxford-AstraZeneca coronavirus vaccine, after Germany suspended its use in the under-60s over concerns about rare blood clots.
Germany to suspend Oxford-AstraZeneca coronavirus vaccine for under-60sGermany will suspend using the Oxford-AstraZeneca vaccine in the under-60s over concerns about rare blood clots.
India extends shelf life of AstraZeneca vaccine: ReportIndia's drug regulator has allowed the AstraZeneca Covid-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed..
AstraZeneca told to 'catch up' on vaccine deliveries to EU before exporting jabs elsewhereEU leaders have told AstraZeneca that it must "catch up" on vaccine deliveries in Europe before it is allowed to export jabs to other countries.
Scientists to test Oxford-AstraZeneca COVID vaccine as a nasal sprayScientists are planning to test the effectiveness of the Oxford-AstraZeneca coronavirus vaccine when it's administered using a nasal spray.
Denmark extends Astra-Zeneca vaccine suspension for 3 weeksDenmark has extended its suspension of the Oxford-AstraZeneca jab for three weeks, as officials continue to investigate reports that it causes blood clots.
No risk of blood clotting from Covishield, says Niti’s PaulThere is no risk of thrombosis or blood clotting due to use of Covishield, Niti Aayog member-health Dr V K Paul said on Wednesday and urged people to get vaccinated without any fear. This comes in the..
‘They have played God with people’s lives’: The story behind Europe’s AstraZeneca blame gameThis is the story about mistrust, anger, blame and death. It's about a relationship that started with high hopes and has now collapsed into acrimony and mistrust.
AstraZeneca denies 'stockpile' claims, saying 29m doses in factory are for EU and developing countriesAstraZeneca has hit back after claims of a stockpile of 29 million doses of its COVID-19 vaccine at a factory near Rome, saying the jabs are for the EU and developing countries.
EU is 'very publicly flexing its muscles' in row with AstraZenecaJust as the European Commission was confirming its plans to tighten the rules around vaccine exports, the Belgian prime minister was talking, just down the road.
AstraZeneca defends COVID vaccine trial data against US claims of possible 'outdated information'AstraZeneca has defended its use of coronavirus vaccine data after US authorities suggested some results from a large American-led trial may have been based on "outdated information".
Increase gap between two doses of Covishield to 6-8 weeks, Centre tells statesThe Centre on Monday said that the gap between the first and second doses of the AstraZeneca-Oxford University's Covishield vaccine should be increased to 6-8 weeks from the current 28 days.The Centre..
Italy, Latvia and Lithuania to resume rollout of Oxford jab after regulator says it's safeItaly, Latvia and Lithuania have said they will resume using the Oxford-AstraZeneca COVID vaccine after the European medicines regulator declared it was "safe and effective".
Anyone with headache for over 4 days after Oxford jab should seek help - UK regulatorPeople who experience a headache for more than four days after having the Oxford-AstraZeneca jab should seek medical attention, the UK's medicines regulator has said.
European regulator says Oxford-AstraZeneca vaccine is 'safe and effective'The European Union's medicines agency has said the Oxford-AstraZeneca coronavirus vaccine is "safe and effective" to use following an investigation into reports of blood clots in a small number of..
Boris Johnson receives first dose of Oxford-AstraZeneca COVID vaccineBoris Johnson has had the Oxford-AstraZeneca coronavirus vaccine.
EU leaders need an efficient vaccine programme to save their reputationsAmidst the turmoil and rancour in Brussels, there is one sure thing today - the name of AstraZeneca will be in the headlines again.
Pfizer and AstraZeneca deny COVID-19 vaccine shortageDrugs giants Pfizer and AstraZeneca have rejected an NHS claim that the UK is facing a COVID-19 vaccine shortage, insisting there is no threat to supplies.
Experts keeping track, no concerns yet: Govt on AstraZeneca safety fears
Assure of no concerns in this regard: Health ministry over AstraZeneca vaccine's 'blood clot' reports
Is the blood-clot scare in Europe over Covishield really justified?Serum Institute’s Covishield is India’s main Covid vaccine. In the West, it is known as the ‘Oxford’ or ‘AstraZeneca’ vaccine. Over the past few days, 11 European countries,..
'If you get the call, get the jab': Health secretary says Oxford-AstraZeneca jab is safeThe Oxford-AstraZeneca coronavirus vaccine is safe, the health secretary has said, urging people in the UK: "If you get the call, get the jab."
Every medicine comes with risks - the certainty is that AstraZeneca's COVID jab saves livesRisk and benefit. Every medicine has it. And it's been brought into sharp focus by the rumble over AstraZeneca's COVID vaccine.
WHO reassures Europe over Oxford jab as experts look into blood clot claimsThe World Health Organization (WHO) is urging countries to continue using the Oxford-AstraZeneca COVID-19 vaccine - as global medical experts meet to discuss reports of blood clots.